FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

AbbVie Zemplar Recall

Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc

AbbVie Inc. · North Chicago, IL

Risk level
Class III
Reported by FDA
Apr 27, 2016
Recall ID
D-0833-2016
Check your lot numberHow we source this data

Summary

AbbVie recalled Zemplar starting Mar 24, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0833-2016 on Apr 27, 2016. Reason: Failed Content Uniformity Specifications. Status: Terminated.

Why it was recalled

Failed Content Uniformity Specifications

Product description

Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30.

Lot numbers, UPCs & expiration codes

Lot #1055586, Exp.1/21/ 2018

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0833-2016
Classification
Class III
Status
Terminated
Recall initiated
Mar 24, 2016
FDA report date
Apr 27, 2016
Quantity
307 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
AbbVie Inc.

Original FDA data

Every field from FDA enforcement report D-0833-2016, exactly as published.

Show all FDA fields
City
North Chicago
State
IL
Status
Terminated
Country
United States
Event ID
73611
Address
1 N Waukegan Rd
Code information
Lot #1055586, Exp.1/21/ 2018
Postal code
60064-1802
Report date
Apr 27, 2016
Product type
Drugs
Recall number
D-0833-2016
Classification
Class III
Recalling firm
AbbVie Inc.
Product quantity
307 bottles
Termination date
Oct 20, 2016
Reason for recall
Failed Content Uniformity Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30.
Distribution pattern
Nationwide
Recall initiation date
Mar 24, 2016
Initial firm notification
Letter
Center classification date
Apr 21, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0833-2016, published Apr 27, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls